Steven Kaufman talks with ONdrugDelivery about the world of autoinjectors, looking at the current status quo in the industry, using Portal Instruments’ PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.
Steven Kaufman discusses the rapidly evolving world of drug delivery and the future of self-injection.
In this exclusive interview, Kaufman highlights the tipping point the industry is facing, driven by a crucial need for sustainability and cost-effectiveness in an era of billions of disposable devices. He sheds light on the next generation of solutions, focusing on the rise of smart, reusable, electromechanical autoinjectors.
Using Portal Instruments' PRIME Nexus™ device as a key example, Kaufman explains how innovative platforms are designed to handle challenges like high-viscosity formulations and varying fill volumes, all while significantly reducing environmental impact. Learn how devices that prioritize the entire value chain, from manufacturing to elegant design and digital health integration, are setting the new standard for improved patient adherence and successful combination product programs.
The full article can be found in ONdrugDelivery.
July 2020 - Portal Instruments has been selected as a finalist for the 2020 New England Innovation Awards. The Massachusetts Innovation Network is pleased to announce the 25 finalists of the Annual New England Innovation Awards, the oldest and longest-running innovation program in New England.
August 29, 2024 - Patrick Anquetil talks with Ryan Cote on the Manufacturer's Mindset Podcast. They discuss insights, challenges, and the lessons learned on the journey of revolutionizing needle-free injections at Portal Instruments.
April 2021 - In the US, approximately 12% of women age 15 to 44 have trouble getting pregnant or carrying a pregnancy to term.¹ To honor National Infertility Week we sat down with Myra, an infertility nurse to talk about the hardships and joys associated with infertility treatment.
Please fill out the details below and we will get back to you shortly.